Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Tuberkulose og molekylaerbiologi

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Remdesivir til behandling af COVID-19-pneumoni

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Varicocele Testis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Integration af specialiseret palliation og onkologi

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Akut luftvejsobstruktion grundet uerkendt akalasi efter ukompliceret vaginal fødsel

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Dansk Kvalitetsdatabase for Nyfødte (DKN) -resumé af årsrapport 2018. Indikator 9: antibiotikabehandling

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Lyme neuroborreliosis in adults: A nationwide prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mycobacterium arosiense, an unexpected cause of osteomyelitis in a patient with sarcoidosis: a case report

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Vi skal blive bedre til at teste for latent tuberkulose i Danmark

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Mycobacterium tuberculosis, the causative agent of tuberculosis (TB) hunting millions worldwide, is a challenge to work with in the laboratory. Modern molecular biology has provided extremely useful tools which have changed conventional diagnostic procedures in the TB laboratories. Research in molecular epidemiology is currently expanding our knowledge of the natural history of TB. Access to the genome sequence has opened new avenues for research in drug development and new vaccines. However, we are still awaiting the impact of these efforts in the resource-poor TB endemic countries.

Translated title of the contributionTuberculosis and molecular biology
Original languageDanish
JournalUgeskrift for Laeger
Volume165
Issue number9
Pages (from-to)920-2
Number of pages3
ISSN0041-5782
Publication statusPublished - 24 Feb 2003

    Research areas

  • English Abstract, Journal Article

ID: 51560100